The increased prevalence of β-lactamases in Pseudomonas aeruginosa has begun to
reduce the clinical efficacy of β-lactams against the most common opportunistic pathogen. Of …

Patients in intensive care units (ICUs) have a higher risk of acquiring hospital-associated
infections than those in non-critical care areas. ICUs are sites of considerable broad …

Objectives To assess the prevalence, levels of antimicrobial susceptibility and resistance
mechanisms of Pseudomonas. Methods A total of 445 clinical isolates and 200 …

We investigated the efficacy of liposomal gentamicin formulations of different surface
charges against Pseudomonas aeruginosa and Klebsiella oxytoca. The liposomal …

Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is an endemic problem in certain
countries including Greece. CRPA and multidrug-resistant P. aeruginosa (MDRPA) firstly …

Background Pseudomonas aeruginosa is a Gram-negative bacteria responsible for
infections in immunocompromised patients and is one of the most common causes of …

A total of 203 clinical isolates of Pseudomonas aeruginosa was collected during 2001–2006
from five university hospitals in Sofia, Bulgaria, to assess the current levels of antimicrobial …

An outbreak of multidrug-resistant Pseudomonas aeruginosa (MDRPA) infections in a
university hospital is described. Phenotypic and genotypic analysis of 240 isolates revealed …

The increasing prevalence of multi-drug–resistant (MDR) strains of Pseudomonas
aeruginosa among critically ill humans is of significant concern. In the current study, we …

Résumé Les bacilles à Gram négatif non fermentants (BGNnF) sont des bactéries
pathogènes opportunistes responsables essentiellement d'infections nosocomiales …